[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"viral-sore-throat\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:viral-sore-throat":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":5},"100636765","evaluation-of-treatments-for-sore-throat-associated-with-acute-pharyngitis-andor-viral-tonsillitis-100636765",false,"NCT07569939","Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and\u002For Viral Tonsillitis","PharyTol","Inclusion Criteria:\n\n* Pharyngitis or tonsillitis or acute nasopharyngitis or viral-origin sore throat with odynophagia that began less than 72 hours before the inclusion visit according to the investigator's judgment\n* Bacterial rhinopharyngitis with negative TROD test\n* Effective contraception for female patients of childbearing age\n* Cooperation and sufficient understanding to comply with the requirements of the trial\n* Acceptance of registration in the SI-RIPH database\n* Having received informed information and agreeing to give written consent\n* Affiliated with the French Social Security scheme.\n\nExclusion Criteria:\n\n* Hypersensitivity\u002Fprevious allergy to any of the product components,\n* Pharyngitis or tonsillitis or acute rhinopharyngitis complicated (phlegmon, acute otitis media, pneumonia…) or severely intolerable cough,\n* Positive antigen test for influenza A\u002FB or COVID-19 and infection requiring etiological treatment according to the recommendations,\n* Other ongoing treatments for acute pharyngitis or tonsillitis (local treatment, antibiotics, corticosteroids, antiretroviral…),\n* Comorbidities or health conditions deemed incompatible with the trial by the investigator,\n* Recent otorhinolaryngology surgery (\\\u003C6 months),\n* Pulmonary pathology (Chronic Obstructive Pulmonary Disease, asthma…),\n* Immunosuppression (according to patient's report),\n* Pregnant or breastfeeding women,\n* Currently participating in another clinical trial, or in the exclusion period, or having received total compensation of more than €6,000 in the 12 months prior to the start of the trial,\n* Benefiting from legal protection measures (guardianship, trusteeship, deprivation of liberty, judicial protection).","ALL","18 Years","70 Years",{"count":20,"type":21},160,"ESTIMATED","INTERVENTIONAL",[24],"NA","The objective of this study is to conduct post-marketing clinical follow-up of four products: HMG, PHN, PHR, and TUR. This follow-up will consist of collecting clinical data in real-life conditions to confirm the tolerance, safety, and efficacy of medical devices used in the treatment of sore throats related to acute pharyngitis and\u002For viral-origin tonsillitis, while also assessing the benefit\u002Frisk ratio of the products.",[27,28],"Acute Pharyngitis","Viral Sore Throat","NOT_YET_RECRUITING","2026-05-06",{"date":32,"type":33},"2026-05-11","ACTUAL",{"date":35,"type":21},"2026-05",{"date":37,"type":21},"2028-01",{"name":39,"class":40},"University Hospital, Clermont-Ferrand","OTHER"]